🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniel Staiculescu

ORCID: 0000-0001-6064-9328
Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma”.

Regorafenib combined with PD1 blockade increases CD8 T-cell infiltration by inducing CXCL10 expression in hepatocellular carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001435
N/A
0.754DataRank · unranked
151 citations

Aya Matsui, Hiroto Kikuchi, Sebastian Klein, Émilie Mamessier, Ivy X. Chen +21 more

Reprogramming Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti-PD1 Therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.26.525680
N/A
0.165DataRank · unranked
2 citations

Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Zelong Liu, Sarah M. Shin +17 more

Role of cellular, molecular and tumor microenvironment in hepatocellular carcinoma: Possible targets and future directions in the regorafenib era

International Journal of Cancer(2020)10.1002/ijc.32970
N/A
0DataRank · unranked
31 citations

Win Topatana, Chen Lü, Daniel Staiculescu, Shijie Li, Jiasheng Cao +6 more

Increased CD8+ T-cell Infiltration and Efficacy for Multikinase Inhibitors After PD-1 Blockade in Hepatocellular Carcinoma

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac051
N/A
0DataRank · unranked
73 citations

Aya Matsui, Satoru Morita, Zohreh Amoozgar, Koetsu Inoue, Zhiping Ruan +7 more

Reprogramming the Intrahepatic Cholangiocarcinoma Immune Microenvironment by Chemotherapy and CTLA-4 Blockade Enhances Anti–PD-1 Therapy

Cancer Immunology Research(2024)10.1158/2326-6066.cir-23-0486
N/A
0DataRank · unranked
28 citations

Zohreh Amoozgar, Xin Liu, Shuichi Aoki, Zelong Liu, Sarah M. Shin +20 more